Oyster Point Pharma, Inc.
USD11.17
+0.00 (+0.00%)
CEO
Jeffrey Nau
IPO Date
2019-10-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.16
Prev. Close
$11.17
Day Low
$11.12
Day High
$11.20
52W Low
$3.46
52W High
$13.45
Volume
2.09M
| 1,850,818 |
| $0.00 |
| 4 Jan 2023 | New Enterprise Associates 14, L.P. | director | U-Tender | Disposed | 5,925,287 | $0.00 |
| 4 Jan 2023 | New Enterprise Associates 14, L.P. | 10 percent owner | U-Tender | Disposed | 5,925,287 | $11.00 |
| 4 Jan 2023 | Ozawa Clare | director | D-Return | Disposed | 11,064 | $0.00 |
| 4 Jan 2023 | Ozawa Clare | director | U-Tender | Disposed | 1,003,658 | $0.00 |
| 4 Jan 2023 | Ozawa Clare | director | D-Return | Disposed | 5,199 | $0.00 |
| 4 Jan 2023 | Versant Venture Capital VI, L.P. | director | U-Tender | Disposed | 1,003,658 | $0.00 |
| 4 Jan 2023 | Versant Venture Capital VI, L.P. | 10 percent owner | U-Tender | Disposed | 1,003,658 | $11.00 |
| 4 Jan 2023 | Nau Jeffrey | President and CEO | F-InKind | Disposed | 2,607 | $11.70 |